Cobra Biomanufacturing Plc (London Stock Exchange AIM) announced that it has strengthened its senior management team. Martin Comberbach PhD, Director of GMP Manufacturing Operations, comes from a pharmaceutical process and project engineering background having held senior positions at GSK’s Rixensart vaccine facility, Metris Therapeutics Ltd, and more recently as Director of Global Manufacturing for GeneMedix Plc.
